management
Last reviewed 11/2022
Seek expert advice.
Management principles are outlined (1):
- management of acute flare ups (1):
- a very short course of systemic corticosteroids or intralesional steroids
may be beneficial
- lesions are often sterile so consider an intra-lesional steroid injection or a short course of oral prednisolone 30-40 mg OD for 3-4 days (4)
- antibiotic treatment
- short courses of antibiotics are usually ineffective in long standing hidradenitis suppuritiva
- however for patients with abscesses, but no cicatrization or sinuses
(Hurley stage I), antibiotics are a good first-line therapy (2)
- if the flare is very explosive consider infection, avoid steroid
therapy and treat with high dose flucloxacillin (or erythromycin
if allergic to penicillin) (4)
- if the flare is very explosive consider infection, avoid steroid
therapy and treat with high dose flucloxacillin (or erythromycin
if allergic to penicillin) (4)
- long term management:
- treatment options include long-term antibiotics (e.g. systemic tetracyclines
or macrolides in doses similar to those used in acne), dianette and acitretin
(1,2). Isotretinoin may benefit some patients (2)
- systemic antibiotics (4)
- prolonged courses (several months to years) are used to reduce
bacterial colonisation and inflammation
- one of the most useful antibiotics is lymecycline 408 mg, which has a strong anti-inflammatory affect in the skin. While the standard dose of lymecycline is one capsule a day on an empty stomach, some patients, especially if obese and / or have moderate-severe symptoms need to take one capsule twice a day - while such a dose is above that recommended, and should be discussed with the patient, it appears to be safe (4)
- some patients may require long-term tetracycline treatment
- other antibiotics used include doxycycline, erythromycin / clarithromycin and metronidazole
- patients failing to respond adequately to a three month course of lymeycyline, or a suitable alternative, should be considered for the combination treatment of clindamycin 300 mg BD and rifampicin 300 mg BD for three months, which appears to be the most effective antibiotic regime
- rifampicin can very occasionally affect the liver and so it is recommended that patients should have their LFTs checked prior to treatment and within the first few weeks of starting treatment. Some patients require repeat / more prolonged courses of this treatment
- prolonged courses (several months to years) are used to reduce
bacterial colonisation and inflammation
- if the disease is severe, immunosuppressive therapy may be used but
with caution as their benefit has to be weighed against their possible
side effects. Such medications include oral corticosteroids, ciclosporin,
mycophenolate mofetil and the biologics, eg infliximab (4)
- NICE have stated that (5):
- adalimumab is a treatment option for for treating active moderate
to severe hidradenitis suppurativa in adults whose disease has
not responded to conventional systemic therapy
- adalimumab is an antibody that inhibits tumour necrosis
factor
- is given by subcutaneous injection
- adalimumab is an antibody that inhibits tumour necrosis
factor
- adalimumab is a treatment option for for treating active moderate
to severe hidradenitis suppurativa in adults whose disease has
not responded to conventional systemic therapy
- NICE have stated that (5):
- botulinum toxin has been shown to be effective for isolated disease
- spironolactone 100-200 mg per day may benefit some patients (4)
- systemic antibiotics (4)
- surgical treatment is an alternative if there is failure of medical therapy - the appropriate technique is via wide excision with secondary intention healing or split-skin grafting
Reference:
- (1) Dermatology in Practice 2001;9 (3), 22-25.
- (2) Alikhan A et a. Hidradenitis suppurativa: A comprehensive review. J Am Acad Dermatol. 2009 Apr;60(4):539-61.
- (3) Dermatology in Practice 2007;15(4):26-28.
- (4) Primary Care Dermatological Society. Hidradenitis suppuritiva (Accessed 29/7/14)
- (5) NICE (June 2016). Adalimumab for treating moderate to severe hidradenitis suppurativa